Maravai LifeSciences Holdings Inc. has announced a change in its certifying accountants, appointing Deloitte & Touche LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. This decision, approved by the company's Audit Committee, follows the dismissal of Ernst & Young LLP. During the fiscal years 2023 and 2024, Ernst & Young reported material weaknesses in Maravai's internal control over financial reporting, particularly concerning revenue, accounts receivable, and goodwill impairment. These issues were outlined in Maravai's 2024 annual report. The Audit Committee has ensured that Deloitte is fully informed about these weaknesses to facilitate a smooth transition.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.